RecruitingNCT07297641

Intravascular Imaging-Guided Versus Angiography- Guided PCI in Patients With DES-ISR

Intravascular Imaging-Guided Versus Angiography- Guided Percutaneous Coronary Intervention for Drug-eluting In-stent Restenosis


Sponsor

Nanjing First Hospital, Nanjing Medical University

Enrollment

1,500 participants

Start Date

Jan 1, 2026

Study Type

OBSERVATIONAL

Conditions

Summary

This study aimed to compare the clinical and angiographic outcomes of patients with DES-ISR who underwent repeat PCI with intravascular imaging or angiographic guidance.


Eligibility

Min Age: 18 YearsMax Age: 80 Years

Inclusion Criteria1

  • (1) Patients with DES-ISR lesions; (2) Life expectancy of at least 1 year; (3) DES-ISR lesions occurring for the first time in native coronary arteries and suitable for re-PCI based on angiographic findings.

Exclusion Criteria1

  • (1) Bare-metal stent in-stent restenosis (BMS-ISR). (2) Non-DES-ISR lesions. (3) Incomplete clinical and angiographic data. (4) Poor quality of IVUS or angiographic images. (5) Recurrent DES-ISR. (6) Optical coherence tomography (OCT) guidance.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

PROCEDUREpercutaneous coronary intervention

Percutaneous Coronary Intervention for ISR


Locations(1)

Nanjing First Hospital

Nanjing, Jiangsu, China

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07297641


Related Trials